XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Note 9 - Income Taxes
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

(9) Income Taxes

 

Components of income tax expense (benefit) for each year are as follows:

 

  

2022

  

2021

 

Current:

        

Federal

 $1,270  $-- 

State

  456   11,967 
         

Current income tax provision (benefit):

  1,726   11,967 
         

Deferred:

        

Federal

  577,866

 

  (2,156,278

)

State

  176,676

 

  (562,667

)

         

Deferred income tax provision (benefit), net

  754,542

 

  (2,718,945

)

         

Total

 $756,268

 

 $(2,706,978

)

 

Deferred tax assets as of December 31, 2022 and December 25, 2021 are as follows:

 

  

December 31, 2022

  

December 25, 2021

 

Deferred Tax Assets:

        

Net operating loss carryforwards

 $132,632  $1,050,449 

Stock compensation

  209,092   157,845 

Credit carryforwards

  1,253,956   1,285,119 

Inventory

  80,628   77,563 

Accrued liabilities

  5,071   12,390 

Depreciation

  179,481   237,880 

Capitalized R&D, net

  205,878   - 

Other

  2,698   2,732 

Net deferred tax assets

 $2,069,436  $2,823,978 

 

At December 31, 2022 and December 25, 2021 the Company had net operating loss carryforwards of approximately $543,404 and $3,768,032, respectively, available to offset future income for U.S. Federal income tax purposes. These net operating loss carryforwards occurred over several years and do not expire.

 

The Company has previously established a valuation reserve against deferred income tax assets.  In September 2021 this decision was reevaluated in light of the Company’s recent profitability and its forecasts for future profitability. The Company concluded that it is “more likely than not” that the Company will be able to fully utilize the deferred tax asset. This reversal of the valuation allowance was made net of the expected tax liability for 2021.

 

A summary of the change in the deferred tax asset is as follows:

 

  

2022

  

2021

 
         

Gross deferred tax balance at beginning of year

 

$

2,823,978

  

$

2,966,693

 
         

Deferred tax benefit (provision)

  

(754,542

)

  

(142,715

)

Valuation allowance

  

0

   

0

 

Balance at end of year, net

 

$

2,069,436

  

$

2,823,978

 

 

Income tax expense is different from the amounts computed by applying the U.S. federal statutory income tax rate of 21 percent to pretax income as a result of the following:

 

  

2022

  

2021

 
         

Tax at statutory rate

 

$

578,214

  

$

106,869

 

State tax, net of federal benefit

  

177,036

   

36,301

 
         

Net operating loss and credit carryforwards

  

--

   

--

 
         

Valuation allowance

  

--

   

(2,849,693

)

         

Other

  

1,018

   

(455

         

Total

 

$

756,268

  

$

(2,706,978

)

 

The Company’s income tax filings are subject to review and examination by federal and state taxing authorities. The Company is currently open to audit under the applicable statutes of limitations for the years 2019 through 2022.